RBM14

RNA-binding protein 14 · Q96PK6 · RBM14 on Sugi Atlas →

0 patent compounds predicted against RBM14, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RBM14 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia PHASE2ACTIVE_NOT_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Prognosis of METTL-14 in Endometrial Carcinoma nanNOT_YET_RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases nanRECRUITING
Search for Bovine miRNA Transference to Humans nanCOMPLETED
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes nanRECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a RBM14 binder may also engage these)

ProteinNameSimilarity
Q5RC41 1.000 Q5RC41 →
Q8C2Q3 1.000 Q8C2Q3 →
Q5EA36 1.000 Q5EA36 →
Q9LJ04 0.971 Q9LJ04 →
Q9JKS4 0.971 Q9JKS4 →
Q10667 0.970 Q10667 →
P35582 0.970 P35582 →
Q7TN99 0.969 Q7TN99 →
A2T7J2 0.968 A2T7J2 →
F4IUY8 0.968 F4IUY8 →
O75112 0.968 O75112 →
P16376 0.968 P16376 →
Q63627 0.968 Q63627 →
Q9SQV1 0.968 Q9SQV1 →
Q9VIV2 0.968 Q9VIV2 →
P14653 0.968 P14653 →
P23441 0.968 P23441 →
P0C1X8 0.968 P0C1X8 →
P43698 0.968 P43698 →
P23512 0.967 P23512 →
A2D4R4 0.967 A2D4R4 →
Q61060 0.967 Q61060 →
Q10R93 0.967 Q10R93 →
P50220 0.967 P50220 →
A6QPR6 0.967 A6QPR6 →
Q8CHU3 0.967 Q8CHU3 →
P47242 0.967 P47242 →
Q80U58 0.967 Q80U58 →
Q0V9A3 0.967 Q0V9A3 →
P09951 0.967 P09951 →